# Repeat Dose Subcutaneous Rhumatoid Arthritis Efficacy Study

> **NCT01101555** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 28 (actual)

## Conditions studied

- Arthritis, Rheumatoid

## Interventions

- **DRUG:** subcutanious administration
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01101555
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05-12
- **Primary completion:** 2011-09-16
- **Final completion:** 2012-11-29
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2022-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01101555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01101555, "Repeat Dose Subcutaneous Rhumatoid Arthritis Efficacy Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01101555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*